[兰格汉斯细胞囊细胞的免疫微环境:从免疫抑制到向治疗]
1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|August 31, 2025
概括
朗格汉斯细胞细胞分裂 (LCH) 涉及异常的树突细胞 (DC) 生长和免疫抑制环境. 新兴疗法针对DC衰老,调节性T细胞和T细胞耗尽,以获得更好的LCH治疗结果.
科学领域:
- 血液学
- 免疫学
- 癌症学
背景情况:
- 朗格汉斯细胞细胞分裂 (LCH) 是一种罕见的血液病.
- 它的特征是瘤树突细胞 (DC) 的克隆增殖.
- LCH表现出不成熟和衰老的免疫表型,创造了一个免疫抑制的微环境.
研究的目的:
- 为了研究兰格汉斯细胞细胞瘤 (LCH) 的免疫微环境.
- 探索当前LCH治疗的挑战,包括复发和耐药性.
- 确定LCH治疗的新兴治疗策略.
主要方法:
- 在LCH中免疫抑制微环境的分析.
- 调节性T (Treg) 细胞,耗尽的CD8 ((+)) T细胞和骨髓衍生抑制细胞的特征.
- 审查当前和新兴的治疗方法.
主要成果:
- 在LCH微环境中,特征是Treg细胞增加,CD8 ((+) T细胞耗尽,以及骨髓衍生抑制细胞.
- 这些细胞集体增强免疫抑制并帮助瘤DC免疫逃避.
- 目前的LCH治疗面临复发和药物耐药性的挑战.
结论:
- 向衰老的瘤DC,抑制Treg活性和逆转T细胞耗尽是有前途的LCH治疗策略.
- 免疫检查点封锁提供了潜在的治疗途径.
- 新兴的策略有望克服当前LCH治疗的局限性.
更多相关视频
相关概念视频
Cell-mediated Immune Responses
72.0K
Overview
72.0K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


